Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Vallejo › NPI 1366686248
Hospital

Sutter Valley Hospitals

Sutter Valley Hospitals was paid $33.28M by Medicaid between Jan 2018 and Dec 2024, across 191 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoSUTTER VALLEY HOSPITALS
VALLEJO, CA 94589
33aNPI1366686248assigned 04/23/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$33.28M
24GClaims530,735
24DCodes billed191
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#87 of 410
Median peer was paid$6.90M
This provider vs. median4.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201893,210$5.04M
201986,282$4.51M
202067,586$3.75M
202172,738$4.57M
202285,659$5.64M
202369,046$4.64M
2024incomplete56,214$5.13M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 67,918 57,181 $6.07M
99281 Emergency department visit for the evaluation and management, self-limited or minor 18% 42,543 36,459 $5.86M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.0% 2,632 2,547 $1.34M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 3.4% 3,690 2,549 $1.14M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.4% 9,253 7,588 $1.13M
77067 Screening mammography, bilateral, including computer-aided detection 3.3% 4,706 4,640 $1.11M
70450 Computed tomography, head or brain; without contrast material 2.6% 3,084 2,998 $880K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.3% 2,852 2,827 $762K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.3% 13,474 12,371 $754K
96375 Therapeutic injection; each additional sequential IV push 2.1% 8,174 6,405 $706K
99201 2.1% 3,868 2,781 $696K
0450 Emergency room services 2.0% 4,859 4,390 $657K
179 more codes
71250 1.9% 2,469 $633K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.7% 2,312 $578K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 1.7% 956 $556K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 3,082 $466K
76700 Ultrasound, abdominal, real time with image documentation; complete 1.3% 2,960 $449K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.3% 7,622 $432K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.1% 2,455 $353K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 4,482 $350K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,654 $320K
76830 Ultrasound, transvaginal <1% 1,993 $290K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 536 $281K
71045 Radiologic examination, chest; single view <1% 10,586 $279K
99284 Emergency room visit (serious) <1% 1,407 $273K
96361 Intravenous infusion, hydration; each additional hour <1% 4,157 $264K
71046 Radiologic examination, chest; 2 views <1% 6,659 $259K
80053 Comprehensive metabolic panel <1% 25,671 $253K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,774 $247K
78815 Positron emission tomography (PET) for limited area imaging <1% 41 $243K
J3490 Unclassified drugs <1% 45,087 $237K
93971 <1% 1,092 $230K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,743 $209K
Z7502 <1% 4,949 $187K
76642 <1% 1,445 $185K
76801 <1% 1,479 $183K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,220 $177K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,363 $165K
73630 <1% 2,954 $152K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 280 $151K
70551 Magnetic resonance imaging, brain; without contrast material <1% 219 $129K
73562 <1% 2,588 $128K
73610 <1% 1,914 $115K
76770 <1% 884 $112K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 825 $112K
73221 <1% 207 $109K
73030 <1% 1,787 $103K
77065 Tomosynthesis, mammo <1% 484 $101K
73130 <1% 1,557 $92K
J7030 Infusion, normal saline solution , 1000 cc <1% 10,155 $90K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,371 $85K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 608 $82K
84484 <1% 8,378 $82K
72100 <1% 1,232 $80K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,797 $78K
99199 Unlisted special service, procedure or report <1% 757 $77K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,096 $75K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 863 $74K
83880 <1% 2,278 $72K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 438 $71K
76536 <1% 691 $70K
74018 <1% 1,701 $70K
77066 Tomosynthesis, mammo <1% 219 $68K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,099 $64K
83690 <1% 9,413 $62K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,215 $58K
81001 <1% 12,704 $56K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,974 $55K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 349 $52K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,922 $52K
82077 <1% 1,577 $51K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,101 $47K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 97 $47K
73110 <1% 812 $46K
87040 <1% 3,204 $42K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 44 $41K
90715 <1% 950 $41K
77063 Screening digital breast tomosynthesis, bilateral <1% 522 $41K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,001 $40K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 958 $36K
73502 <1% 568 $35K
83605 <1% 3,278 $33K
93017 <1% 204 $33K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,066 $30K
71275 Computed tomographic angiography, chest, with contrast material <1% 52 $27K
80048 Basic metabolic panel (calcium, ionized) <1% 3,284 $25K
80143 <1% 728 $24K
93351 <1% 60 $23K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,702 $23K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 317 $22K
80179 <1% 701 $22K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,042 $22K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,367 $22K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,346 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 49 $20K
81025 <1% 5,704 $20K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,949 $20K
87077 <1% 2,104 $19K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $18K
87186 <1% 1,902 $18K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 650 $18K
J2704 Injection, propofol, 10 mg <1% 2,196 $17K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,342 $17K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,467 $16K
83735 <1% 2,368 $14K
84443 Thyroid stimulating hormone (TSH) <1% 719 $12K
85610 <1% 3,088 $12K
85730 <1% 1,875 $11K
81003 <1% 4,360 $11K
73140 <1% 342 $11K
J7050 Infusion, normal saline solution, 250 cc <1% 1,508 $11K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,265 $11K
A9585 Injection, gadobutrol, 0.1 ml <1% 473 $11K
82947 <1% 2,381 $10K
82803 <1% 733 $10K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,331 $9K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 13 $9K
J2060 Injection, lorazepam, 2 mg <1% 1,297 $8K
72040 <1% 128 $8K
70486 <1% 27 $8K
73080 <1% 146 $8K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 913 $8K
76870 <1% 64 $7K
J1815 Injection, insulin, per 5 units <1% 422 $7K
99070 <1% 339 $7K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 88 $7K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 13 $6K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 28 $6K
86900 <1% 2,037 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 14 $6K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 308 $5K
84702 <1% 376 $5K
74019 <1% 85 $4K
86901 <1% 1,590 $4K
94644 <1% 119 $4K
12001 <1% 104 $4K
J2785 Injection, regadenoson, 0.1 mg <1% 26 $4K
87400 <1% 394 $4K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 528 $4K
87430 <1% 236 $3K
87081 <1% 290 $3K
10060 <1% 58 $3K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 167 $2K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 214 $2K
86850 <1% 693 $2K
Z7610 <1% 233 $2K
86922 <1% 27 $2K
73590 <1% 13 $2K
93350 <1% 13 $2K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 29 $2K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 197 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 119 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $2K
96367 <1% 19 $1K
94729 <1% 13 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 128 $1K
85379 <1% 140 $1K
94726 <1% 13 $1K
84100 <1% 330 $1K
71101 <1% 12 $1K
84132 <1% 297 $1K
36415 Collection of venous blood by venipuncture <1% 297 $1K
71020 <1% 22 $1K
94060 <1% 13 $932.10
87210 <1% 142 $849.23
J1650 Injection, enoxaparin sodium, 10 mg <1% 61 $817.38
J1940 Injection, furosemide, up to 20 mg <1% 84 $620.24
73521 <1% 12 $569.64
74000 <1% 18 $507.11
83036 Hemoglobin; glycosylated (A1C) <1% 39 $503.53
84295 <1% 159 $488.68
S0028 Injection, famotidine, 20 mg <1% 64 $482.77
29125 <1% 26 $437.87
S0164 Injection, pantoprazole sodium, 40 mg <1% 38 $431.71
0250 <1% 23 $413.74
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 25 $367.44
87420 <1% 68 $269.88
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 517 $215.97
87088 <1% 32 $197.64
J2550 Injection, promethazine hcl, up to 50 mg <1% 19 $159.90
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 13 $152.49
85027 <1% 32 $148.55
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 29 $129.34
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 512 $118.55
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 19 $117.95
A4217 Sterile water/saline, 500 ml <1% 12 $99.19
82009 <1% 12 $85.92
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 54 $78.24
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 38 $68.86
87205 <1% 12 $51.90
85652 <1% 26 $46.55

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCONFORTI, JAMES (PRESIDENT/CEO)
Parent organizationSUTTER VALLEY HOSPITALS
Same official

Other billing entities under CONFORTI, JAMES

Full network →
ProviderLocationPaid
Sutter Valley HospitalsRoseville, CA$81.16M
Sutter Valley HospitalsDavis, CA$20.04M
Sutter Valley HospitalsAuburn, CA$15.54M
Sutter Valley HospitalsJackson, CA$11.20M
Sutter Valley HospitalsSacramento, CA$3.16M
Sutter Valley HospitalsAuburn, CA$165K
Sutter Valley HospitalsAuburn, CA$25K
Sutter Valley HospitalsSacramento, CA$71.31
Sutter Valley HospitalsRoseville, CA$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.